Sanuwave Health (SNWV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more str
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q3 2025 Earnings Call October 6, 2025 5:30 PM EDT Company Participants Morgan Frank - CEO & Chairman Conference Call Participants Kyle Bauser - ROTH Capital Partne
Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history.
The global healthcare market is growing rapidly—it is expected to climb at a 6.9% CAGR over the next eight years, reaching more than $22.3 trillion by 2033. Its appeal to investors in the current ma
Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver have
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Morgan C. Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call P

Sanuwave (SNWV) Q2 Revenue Jumps 42%

06:22am, Friday, 08'th Aug 2025
Sanuwave (SNWV) Q2 Revenue Jumps 42%

Sanuwave Announces Q2 FY2025 Financial Results

06:00am, Friday, 08'th Aug 2025
Q2 2025 revenues were $10.2 million , up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history.
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, wil
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Fran
Sanuwave's UltraMIST offers superior wound care, reducing costs and healing time for hospitals, making it attractive to both providers and insurers. Under new CEO Morgan Frank, Sanuwave has revitalize
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 20
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is p
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and CEO Peter Sorensen - CFO Conference Call Participants Carl
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE